Portage Biotech Inc. (PRTG) Misses Q2 EPS by 98c

Portage Biotech Inc. (NASDAQ: PRTG) reported Q2 EPS of ($1.25), $0.98 worse than the analyst estimate of ($0.27).

For earnings history and earnings-related data on Portage Biotech Inc. (PRTG) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c
• Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c